3 Business Models That Could Bring Million-Dollar Cures to Everyone
Harvard Business
NOVEMBER 12, 2018
In a recent Goldman Sachs research report about the promise of gene therapies, analysts asked a question that gets to the heart of a growing dilemma for the healthcare sector: “Is curing patients a sustainable business model?” But there was a catch: the one-time treatment, Luxturna from Spark Therapeutics, costs $850,000.
38 
Let's personalize your content